{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "122793", "DateCompleted": {"Year": "1975", "Month": "03", "Day": "18"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0098-7484", "JournalIssue": {"Volume": "231", "Issue": "4", "PubDate": {"Year": "1975", "Month": "Jan", "Day": "27"}}, "Title": "JAMA", "ISOAbbreviation": "JAMA"}, "ArticleTitle": "Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone.", "Pagination": {"StartPage": "352", "EndPage": "355", "MedlinePgn": "352-5"}, "Abstract": {"AbstractText": ["Four non-Chinese patients, middle-aged or older, developed agranuloctyosis while taking Chinese herbal medicines for relief of arthritis and back pain. All four developed life-threatening infections with bacterial sepsis; one died. The herbal medicines were shown to contain substantial amounts of undeclared aminopyrine and phenylbutazone, drugs that are well-known causes of agranulocytosis. These Chinese herbal medicines are widely available over the counter throughout the United States."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Ries", "ForeName": "C A", "Initials": "CA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sahud", "ForeName": "M A", "Initials": "MA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "JAMA", "NlmUniqueID": "7501160", "ISSNLinking": "0098-7484"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Nonprescription Drugs"}, {"RegistryNumber": "01704YP3MO", "NameOfSubstance": "Aminopyrine"}, {"RegistryNumber": "GN5P7K3T8S", "NameOfSubstance": "Phenylbutazone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["etiology"], "DescriptorName": "Agranulocytosis"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Aminopyrine"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Arthritis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Back Pain"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Bacteroides"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Escherichia coli"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Magnoliopsida"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": [], "DescriptorName": "Medicine, East Asian Traditional"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Nonprescription Drugs"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Phenylbutazone"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Pseudomonas"}, {"QualifierName": ["diagnosis"], "DescriptorName": "Sepsis"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Staphylococcus"}, {"QualifierName": [], "DescriptorName": "United States"}, {"QualifierName": [], "DescriptorName": "White People"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1975", "Month": "1", "Day": "27"}, {"Year": "1975", "Month": "1", "Day": "27", "Hour": "0", "Minute": "1"}, {"Year": "1975", "Month": "1", "Day": "27", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["122793"]}}]}